CLINICAL_TRIALS
trial_result
· 2024-04-19
Clinical Trial Update: A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927 [Phase 2]
Summary
Phase 2 trial update evaluating safety, tolerability, and pharmacokinetics of intravenous SPM 927 in epilepsy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 2 | Status: COMPLETED